Deontological Ethical Analysis of Direct-to-Consumer Pharmaceutical Marketing In Deontological ethics‚ morality of an action is based upon the particular action’s adherence to moral laws independent of their consequences (DeGeorge 62). Direct-to-consumer marketing of pharmaceuticals has had heated debate with logical arguments from those for‚ and for those against allowing such practices to exist. I do not believe the marketing of the prescription medication to be solely unethical but more
Premium Marketing Pharmacology Pharmaceutical industry
patients” (Abraham 2010:604). According to Abraham (2010)‚ pharmaceuticalization is currently on an upward spiral and this dramatic increase can be attributed to five different factors. These five explanations are biomedicalism‚ medicalization‚ pharmaceutical industry promotion and marketing‚ consumerism‚ and regulatory-state ideology or policy. Each of these explanatory factors are mutually interactive but competing and it will be explained how this is in the following paragraphs. The biomedicalization
Premium Attention-deficit hyperactivity disorder Pharmacology Medicine
Counterfeit Drugs Problems and Solutions for the Indian Pharmaceutical Industry Introduction Counterfeit drugs have been around for much of the recent history of industrial-scale drug production in India and abroad. Although detailed data on counterfeit medicines are difficult to obtain by virtue of its very nature‚ a recent WHO report estimates the prevalence to be around 1% of sales in developed countries to over 10% in some developing countries1. The more important aspect of this global
Premium Pharmaceutical industry Authentication Pharmacology
The "Pharmaceutical Excipients Market [By Products (Carbohydrates‚ Oleochemicals‚ Petrochemicals‚ Polymers‚ Microcrystalline Cellulose‚ Sugar‚ Calcium carbonate)‚ By Functionality (Fillers‚ Binders‚ Lubricants‚ Preservatives)] – Global Forecast to 2018 " analyzes and studies the major market drivers‚ restraints‚ and opportunities in North America‚ Europe‚ Asia-Pacific‚ and the Rest of the World. Browse 112 market data tables with 48 figures spread through 315 pages and in-depth TOC on "Pharmaceutical
Premium North America Pharmacology Pharmaceutical industry
products in Pakistan. Wellcome produces Septran‚ whereas the other two are Beecham’s products. The sales of each of these three products are approximately $6 million to $9 million‚ larger than the total sales of many medium sized companies in the pharmaceutical industry in Pakistan. The following table shows the value sales of the top 10 products: Table 2: THE VALUE SALES OF THE TOP 10 PRODUCTS | |
Premium Pharmaceutical industry Corporation Limited company
Quality Management on Domestic and Global Competition In Pakistan‚ Sanofi-Aventis and GlaxoSmithKline are pharmaceutical companies that market popular products and carry very similar medications. Companies like these have the mission and responsibility of providing medicines and vaccinations to better people’s live in different countries and communities. One of the largest and leading pharmaceutical companies in Pakistan is the Sanofi-Aventis Pakistan Limited. The chains put most of their focus on
Premium Pharmaceutical industry Pharmacology
factors that shaped the competition within pharmaceutical industry. It will look at the key players in the market and try to answer how they obtained the competitive advantage over their rivals. Moreover his paper will also examine the main business models in pharmaceutical industry and look how the companies react to the changing nature of competition‚ by re-assessing their strategies. According to the case‚ written by Holland & Batiz (2004)‚ the pharmaceutical industry has its roots in 19th century
Premium Strategic management Pharmaceutical industry Generic drug
1. Introduction The purpose of this report is to critically assess current purchasing and supply management practices in pharmaceutical industry‚ while looking at such companies as “Pfizer Inc.” and “Eli Lilly and Company”. Globalization‚ technological advances and increased worldwide competition has led to more complex supply chains in the pharmaceutical industry. It is important to acknowledge the increased exposure of these supply chains to risk. ‘The purpose of risk management is to ensure that
Premium Management Supply chain management Risk management
COMMENTARY Aseptic Processing Contamination Case Studies and the Pharmaceutical Quality System Richard L. Friedman Food & Drug Administration‚ Center for Drug Evaluation & Research‚ Division of Manufacturing & Product Quality ABSTRACT: This paper summarizes parenteral drug contamination case studies presented at industry conferences and a Food and Drug Administration advisory committee meeting in the period of 2000-2004. CGMP deficiencies associated with each contamination event are discussed. The
Premium Pharmacology Chemical engineering Food and Drug Administration
III.1. USE AND LIMITATIONS OF PESTEL 5 III.2. USE AND LIMITATIONS OF FIVE FORCES MODEL 6 SUMMARY 6 APPENDIX 1 8 APPENDIX 2 9 REFERENCES 10 INTRODUCTION The origin of the modern pharmaceutical industry can be traced to the late 19th century. There are five broad types of industry players: Ethical‚ Generic‚ Biotech‚ OTC‚ and Vaccine companies. Ethical drug is key sector with 80% of market share by value and 50% by volume. Key markets
Premium Strategic management Pharmaceutical industry Generic drug